Source: Virtual Congress 2021 – COVID - 19 risk predictions



Rating:

Share or cite this content

Citations should be made in the following way:
I. Lizinfeld (Moscow, Russian Federation), N. Pshenichnaya (Moscow, Russian Federation), L. Parolina (Moscow, Russian Federation), G. Zhuravlev (Moscow, Russian Federation). Input of comorbidities to hospitalization of patients with COVID-19.. 3657

Member's Comments

No comment yet.

Related content which might interest you: Hospitalisation of COPD patients due to comorbidity Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008 Predicting hospital readmissions in severe COPD patients using an electronic-nose. Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Analysis of patients with COPD requiring mechanical ventilation: characteristics, outcomes and risk factors for hospital mortality Source: Annual Congress 2009 - Intensive care unit management and outcome Year: 2009 Predictors of mortality in COPD patients after hospitalization due to an exacerbation Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Identifying COPD patients at risk of frequent hospital admission Source: Eur Respir J 2006; 28: Suppl. 50, 32s Year: 2006 Exacerbation types by COPD severity; risk of hospitalisation by patients not seeking treatment Source: Eur Respir J 2003; 22: Suppl. 45, 353s Year: 2003 Risk factors of ICU admission and death among hospitalized patients with Influenza(H1N1) Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis Year: 2010 Prevalence of comorbidities in patients with COPD in south-Spain Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Risk contribution of comorbidities in hospitalized patients with Covid 19 pneumonia Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021 Gender aspect of comorbidities in COPD patients in primary care. Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Comparison of hospitalization risk for Medicaid patients with COPD by medication regimen Source: Eur Respir J 2003; 22: Suppl. 45, 375s Year: 2003 Clinical features associated with mortality in patients with community acquired pneumonia requiring hospitalisation Source: Eur Respir J 2004; 24: Suppl. 48, 414s Year: 2004 Impact of home hospitalization on treatment compliance in COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 207s Year: 2001 Impact of disease severity and comorbidities on length of stay (LOS) in COPD Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Efficacy of using special software “Optimization of medication choice for treatment of patient with comorbidity” (SS) for management of patients with community-acquired pneumonia (CAP) and cardiovascular disease Source: International Congress 2019 – M-health/e-health I Year: 2019 Co-morbidity and hospitalization rate in patients (pts) with acute exacerbation (AE) of COPD Source: International Congress 2015 – Different data in COPD Year: 2015 Key factors associated with readmission in COPD patients Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Risk factors for long-term hospitalization in patients with COVID 19 Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021 LATE-BREAKING ABSTRACT: Baseline demographic and clinical profile of patients with and without cardiovascular diseases in the assessment of comorbidities in COPD in european symptomatic subjects from primary care (ACCESS) study Source: Annual Congress 2013 –A modern approach to lung diseases: from bronchi to pleura Year: 2013